丝氨酸蛋白酶SNC19及其抑制因子在胃癌中的表达
被引量:5
出处
《中华消化杂志》
CAS
CSCD
北大核心
2004年第7期429-430,共2页
Chinese Journal of Digestion
基金
国家自然科学基金资助项目 ( 3 0 2 714 5 0 )
参考文献4
-
1Cao J, Zheng S, Zheng L, et al. A novel serine protease SNC19 associated with human colorectal cancer. Chin Med J (Engl), 2001,114: 726-730.
-
2Oberst MD, Johnson MD, Dickson RB, et al. Expression of the serine protease matriptase and its inhibitor HAI-I in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res, 2002, 8: 1101-1107.
-
3Giuliettil A, Overbergh L, Valckx D, et al. An overview of realtime quantitative PCR: applications to quantify cytokine gene expression. Methods,2001, 25:386-401.
-
4Kataoka H, Uchino H, Denda K, et al. Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa. Cancer Lett, 1998, 128: 219-227.
同被引文献72
-
1Lei Zeng,Jiang Cao,Xing Zhang.Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract[J].World Journal of Gastroenterology,2005,11(39):6202-6207. 被引量:9
-
2Oberst M, Anders J, Xie B, et al. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol, 2001, 158(4) :1301-1311.
-
3Tsai WC, Sheu LF, Chao YC, et al. Decreased matriptase/HAI- 1 ratio in advanced colorectal adenocarcinoma of Chinese patients. Chin J Physiol, 2007, 50(5) :225-231.
-
4Saleem M, Adhami VM, Zhong W,et al. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor- 1. Cancer Epidemiol Biomarkers Prev, 2006, 15 ( 2 ) : 217- 227.
-
5Tsai WC, Chu CH, Yu CP, et al. Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women : tissue mieroarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers, 2008, 24 (2) :89-99.
-
6Jin JS, Cheng TF, Tsai WC, et al. Expression of the serine protease, matriptase, in breast ductal carcinoma of Chinese women: correlation with clinicopathological parameters. Histol Histopathol, 2007, 22 (3) :305-309.
-
7Tsai WC, Chao YC, Lee WH, et al. Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue mieroarray analysis of immunohistochemical scores with clinicopathological parameters. Histopathology, 2006, 49(4):388-395.
-
8Cheng MF, Tzao C, Tsai WC, et al. Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters. Dis Esophagus, 2006, 19 ( 6 ) : 482- 486.
-
9Jin JS, Hsieh DS, Loh SH, et al. Increasing expression of serine protease matriptase in ovarian tumors : tissue microarray analysis of immunostaining score with clinicopathological parameters. Mod Pathol, 2006, 19 (3) :447-452.
-
10Vogel LK, Saebφ M, Skjelbred CF, et al. The ratio of Matriptase/ HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals. BMC Cancer, 2006, 4: 61-76.
引证文献5
-
1曹江,叶景佳.HAI-1过表达对SW620细胞体外生长和运动能力的影响[J].实验生物学报,2005,38(3):183-189. 被引量:2
-
2周振玉,姚茂银.HAI-1和SNC19(ST14)/Matriptase基因的研究进展[J].海南医学,2008,19(9):129-131.
-
3周振玉,苏昀,胡向农,杨建军,姚茂银.Matriptase和HAI-1在膀胱移行细胞癌中的表达及其意义[J].国际肿瘤学杂志,2008,35(9):714-718.
-
4周振玉,苏昀,胡向农,杨建军,姚茂银.新型丝氨酸蛋白酶Matriptase在膀胱移行细胞癌中的表达及意义[J].医学临床研究,2008,25(11):2015-2017. 被引量:1
-
5林远茂,施荣聪,孙诚攻,周坤林,陈艳红,郑秋霞,林晓涛,姜枫.基于网络药理学分析北刘寄奴的活性成分及其药效作用机制[J].中医药导报,2020,26(10):46-51. 被引量:17
二级引证文献20
-
1孙国娟,谢萍.谢萍教授治疗盆腔脓肿经验[J].四川中医,2022,40(9):4-7.
-
2胡晓燕,曹江.肝细胞生长因子激活因子抑制因子-1的表达与功能[J].医学分子生物学杂志,2007,4(6):527-530.
-
3程海霞,曹江,吴晴,郑树.HAI-1蛋白在人正常及肿瘤组织中的表达研究[J].中国肿瘤临床,2008,35(7):383-386. 被引量:1
-
4张永,周振玉,陈家存,苏昀.Matriptase和HAI-1基因与前列腺癌关系的研究[J].中国医师杂志,2011,13(5):587-591.
-
5李宝华,陈刚毅.基于网络药理学的肾炎康复片治疗糖尿病肾病的潜在作用机制研究[J].中医药导报,2021,27(2):143-150. 被引量:2
-
6王丽虹,王建荣,刘仁根.2019、2020年上半年我院儿童中药饮片使用情况分析[J].海峡药学,2021,33(6):172-174.
-
7陆晨星,陈凤华,许炜民.许氏伤药外敷治疗踝关节骨折29例[J].环球中医药,2021,14(11):2079-2082. 被引量:3
-
8杨珂娜,俞竟一,王志莉,常克(指导).常克教授治疗小儿蛋白尿经验[J].中医儿科杂志,2021,17(6):32-34. 被引量:1
-
9祁建华,明洪,张会择,胡友鹏,戴泽林,杨斐,陈日高.基于数据挖掘法探讨《世医得效方》中治伤方剂的用药规律[J].中医正骨,2022,34(3):20-25. 被引量:1
-
10乔江,王叶,吴肖男,刘祎,陈智芬.丹荔输通汤对慢性输卵管炎模型大鼠干预作用的实验研究[J].湖南中医杂志,2022,38(5):182-186.
-
1杨柳,姚默,刘向辉,罗海羽,赵洁,段双艳,巩江,倪士峰.乳腺癌诱因研究概况[J].辽宁中医药大学学报,2012,14(3):96-98. 被引量:5
-
2徐旸,彭佳萍,郑树,叶锋,曹江.新的丝氨酸蛋白酶基因ST14(SNC19)在大肠癌中的表达研究[J].实用肿瘤杂志,2001,16(6):391-393. 被引量:2
-
3胡晓晔,郑树,彭佳萍.新型丝氨酸蛋白酶SNC19(ST14)基因编码蛋白在大肠癌中的表达[J].实用肿瘤杂志,2003,18(4):275-279. 被引量:3
-
4郑树,蔡心涵,曹江,郑雷,莫益群,张颜明,耿礼义,施正政,顾健人.减式杂交筛检大肠癌负相关基因的研究[J].中华医学杂志,1997,77(4):256-259. 被引量:15
-
5孙立峰,郑树,史影,方晓明,葛维挺,丁克峰.SNC19/ST14表达对大肠癌细胞生物学行为的影响[J].中华医学杂志,2004,84(10):843-848. 被引量:3
-
6王艳霞.子宫内膜癌高危因素及预防[J].齐鲁护理杂志,2006,12(08B):1627-1628. 被引量:1
-
7张慧明,葛智成,王子函,苑著,高银光,赵宁,藤长胜,张忠涛,屈翔.甲状腺乳头状癌外科治疗效果分析[J].实用医学杂志,2014,30(5):805-807. 被引量:10
-
8刘锋,张建中,马敏,韩恩善.涎腺腺样囊性癌p16蛋白和增殖细胞核抗原的表达[J].宁夏医学院学报,2006,28(4):280-282.
-
9周振玉,姚茂银.HAI-1和SNC19(ST14)/Matriptase基因的研究进展[J].海南医学,2008,19(9):129-131.
-
10曹江,郑树,郑雷,蔡心涵,张颜明,耿礼义,方永明.一个新的人大肠癌相关丝氨酸蛋白酶SNC19的研究(英文)[J].Chinese Medical Journal,2001(7):54-58.